MHS
SEEL

M Holdings Securities’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

M Holdings Securities’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$372K Sell
37
-3
-8% -$49.3K 0.04% 206
2021
Q1 		$767K Buy
+40
New +$467K 0.07% 222

Other funds holding SEEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

M Holdings Securities's SEEL Position: Q2 2021 in Review

M Holdings Securities reduced its Seelos Therapeutics, Inc. Common Stock (SEEL) stake by 7.5% in Q2 2021, selling an estimated $49.3K and leaving 37 shares worth $372K. The position accounts for 0.04% of the portfolio, ranked #206.

M Holdings Securities first reported a position in SEEL in Q1 2021 and has held it in 2 quarters since. The position peaked at $767K in Q1 2021. 92 funds tracked by Wall St. Rank hold SEEL as of Q2 2021.

  • M Holdings Securities held 37 shares of Seelos Therapeutics, Inc. Common Stock worth $372K as of Q2 2021.
  • M Holdings Securities sold 3 Seelos Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $49.3K.
  • Seelos Therapeutics, Inc. Common Stock made up 0.04% of M Holdings Securities's portfolio in Q2 2021, its #206 holding.
  • M Holdings Securities first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2021 and has held it in 2 quarters since.
  • M Holdings Securities's Seelos Therapeutics, Inc. Common Stock position peaked at $767K in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.